Latest Oncology Stories
DSMB's recommendation follows 1(rst) interim analysis QUÉBEC CITY, April 27, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
Odds are, most people at one point in their childhood blamed their “evil twin” when something went wrong or was broken. But as it turns out, doctors recently discovered an Indiana woman’s brain tumor actually was caused by an “evil twin”...sort of.
A new study suggests that deadly malignant mesothelioma is more common in the regions around asbestos cement plants – even among people who never worked in them. Raleigh,
More than 500 oncology professionals hear of advances in knowledge-based applications and optimization of imaging data at 'Knowledge is Power' symposium hosted by Varian Medical Systems
WASHINGTON, April 24, 2015 /PRNewswire/ -- The Mesothelioma Compensation Center is now offering instant access to the nation's most skilled mesothelioma compensation lawyers if a family has
The adoption of Syapse Precision Medicine Platform will help deliver large-scale genomic and clinical data to enhance patient care SEATTLE, April 23, 2015 /PRNewswire-USNewswire/ --
Presentations to Highlight MRIdian Clinical Implementation and its Role in On-table Adaptive Therapy CLEVELAND, April 23, 2015 /PRNewswire/ -- ViewRay(TM), makers of the world's first
Long-term health care practices for childhood cancer survivors are the focus of a new white paper published by The National Children’s Cancer Society (NCCS), a nonprofit organization helping
The Mesothelioma Applied Research Foundation is optimistic about the results of the Phase 1b trial of pembrolizumab for PD-L1-positive advanced solid tumors, which were announced at the most recent
Dr. O'Shea has been recognized as an "NJ Top Doc" since 2012. Scotch Plains, NJ (PRWEB) April 22, 2015 Dr.
- A serpent whose bite was fabled to produce intense thirst.